References
Alter BP, Potter NU, Li FP (1978) Classification and aetiology of the aplastic anaemias. Clin Haematol 7: 431–465
Anderson MJ (1982) The emerging story of a human parvovirus-like agent. J Hyg Camb 89: 1–8
Anderson MJ, Davis LR, Jones SE, Pattison JR, Sergeant GR (1982) The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg Camb 88: 309–324
Appelbaum R, Ferer A (1981) The pathogenesis of aplastic anemia. Semin Hematol 18: 241–257
Bacigalupo A, Podesta M, Van Lint MT, Vimercati R, Cerri R, Rossi E, Risso M, Carella A, Santini G, Damasio E, Giordano D, Marmont AM (1981) Severe aplastic anaemia: correlation of in vitro tests with clinical response to immunosuppression in 20 patients. Br J Haematol 47: 423–433
Barrett AJ, Faille A, Balitrand N, Ketels F, Najean Y (1979) Bone marrow culture in aplastic anaemia. J Clin Pathol 32: 660–665
Benestad HB (1974) Aplastic anaemia: considerations on the pathogenesis. Acta Med Scand 196: 255–262
Boggs DR, Boggs SS (1976) The pathogenesis of aplastic anemia: a defective pluripotent hematopoietic stem cell with inappropriate balance of differentiation and self-replication. Blood 48: 71–76
Boggs DR, Boggs SS (1978) Possible pathogenic mechanisms in aplastic anemia. Transplant Proc 10: 125–130
Camitta BM, Storb R, Thomas ED (1982) Aplastic anemia. Pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 306: 645–652
Cline MJ, Golde DW (1978) Immune suppression of hematopoiesis. Am J Med 64: 301–310
Cline MJ, Golde DW (1979) Cellular interactions in haematopoiesis. Nature 227: 177–181
Cossart YE, Cant B, Field AM, Widdows D (1975) Parvovirus-like particles in human sera. Lancet 1: 72–73
Cunningham JL, Leyland MJ, Delamore IW, Price Evans DA (1974) Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia. Br Med J 3: 313–317
Dexter TM, Schofield R, Hendry J, Testa NG (1979) Congenital and induced defects in haemopoietic environments, stem cell proliferation and differentiation. In: Heimpel H, Gordon-Smith EC, Heit W, Kubanek B (eds) Aplastic anemia: pathophysiology and approaches to therapy. Springer, Berlin, pp 73–78
Editorial (1976) Mechanisms in aplastic anaemia. Lancet 2: 1179–1181
Editorial (1977) Aplastic anaemia: Seed or soil? Lancet 2: 748–750
Fitchen JH, Cline MJ (1978) Recent developments in understanding the pathogenesis of aplastic anemia. Am J Hematol 5: 365–372
Firkin FC, Moore MAS (1977) Atypical phenylbutazone sensitivity of marrow colony forming units in phenylbutazone-induced asplast anemia. In: Hibino S, Takaku F, Shahidi NT (eds) Aplastic anemia. University Park Press, Baltimore London Tokyo, pp 335–342
Gurney CW, Lyon JW, Simmons EL, Gaston EO, Malcolm BA (1979) Treatment of Strontium-89-induced hypoplastic anemia in mice by intraperitoneal implants of spleen slices. In: Baum SJ, Ledney GD (eds) Experimental hematology today 1979. Springer, New York Heidelberg Berlin, pp 105–110
Haak HL (1980) Experimental drug-induced aplastic anaemia. Clin Haematol 9: 621–639
Hara H, Kai S, Fushimi M, Taniwaki S, Okamoto T, Ohe Y, Fujita S, Noguchi K, Senba M, Hamano T, Kanamaru A, Nagai K (1980) Pluripotent hemopoietic precursors in vitro (CFUMIX) in aplastic anemia. Exp Hematol 8: 1165–1171
Heimpel H, Heit W (1980) Drug-induced aplastic anaemia: clinical aspects. Clin Haematol 9: 641–662
Heit W, Kern P, Heimpel H, Kubanek B (1977) Granulocytic colony forming cells in vitro: I. Patients with drug induced agranulocytosis. Blut 34: 403–405
Hinterberger W, Muhar U, Müller R, Jürgenssen O-A, Kabrna E, Paukovits WR (1981) Coexisting suppressor cells for myeloid colony formation in the bone marrow of patients with aplastic anaemia. Scand J Haematol 26: 345–350
Hoffman R, Zanjani ED, Lutton JD, Zalusky R, Wasserman LR (1977) Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. N Engl J Med 296: 10–13
Howell A, Andrews TM, Watts RWE (1975a) Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced asplastic anaemia. Lancet 1: 65–69
Howell A, Gumpel JM, Watts RWE (1975b) Depression of bone marrow colony formation in gold-induced neutropenia. Br Med J 1: 432–434
Kelton JG, Huang AT, Mold N, Logue G, Rosse WF (1979) The use of in vitro technics to study drug-induced pancytopenia. N Engl J Med 301: 621–624
Kern P, Heimpel H, Heit W, Kubanek B (1975) Bone-marrow cells resistant to chloramphenicol in chloramphenicol-induced aplastic anaemia. Lancet 1: 1190
Kern P, Heimpel H, Heit W, Kubanek B (1977) Granulocytic progenitor cells in aplastic anaemia. Br J Haematol 35: 613–623
Klassen LW, Birks J, Allen E, Gurney CW (1972) Experimental medullary aplasia. J Lab Clin Med 80: 8–17
Knospe WH, Crosby WH (1971) Aplastic anaemia: a disorder of the bone-marrow sinusoidal microcirculation rather than stem-cell failure? Lancet 1: 20–22
Levere RD, Ibraham NG (1982) The bone marrow as a metabolic organ. Am J Med 73: 615–616
Lind DE, Levi JA, Vincent PC (1973) Amodiaquine-induced agranulocytosis: Toxic effect of amodiaquine in bone marrow cultures in vitro. Br J Med 1: 458–460
Morley A, Blake J (1974) An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan. Blood 44: 49–56
Morley A, Blake J (1974) Haemopoietic precursor cells in experimental hypoplastic marrow failure. Aust J Exp Biol Med Sci 52: 909–914
Morley A, Trainor K, Blake J (1975) A primary stem cell lesion in experimental chronic hypoplastic marrow failure. Blood 45: 681–687
Morley A, Trainor K, Remes J (1976) Residual marrow damage: Possible explanation for idiosyncrasy to chloramphenicol. Br J Haematol 32: 525–531
Morley A, Trainor K, Seshadri R, Sorrell J (1978) Is aplastic anaemia due to abnormality of D.N.A.? Lancet 2: 9–11
Morris TCM, Vincent PC, Young GAR, Sutherland R, Forrest P, Isbister JP (1984) CFU-C inhibitors in aplastic anaemia. Blut 48: 1–14
Mortimer P (1983) Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent. J Clin Pathol 36: 445–448
Nagao T, Mauer AM (1969) Concordance for drug-induced aplastic anemia in identical twins. N Engl J Med 281: 7–11
Nara N, Bessho M, Hirashima K, Momoi H (1982) Effects of Chloramphenicol on hematopoietic inductive microenvironment. Exp Haematol 10: 20–25
Nieweg HO (1974) Aplastic anemia (panmyelopathy) In: Girdwood RH (ed) Blood disorders due to drugs and other agents. Excerpta Med, Amsterdam, pp 83–106
Pisciotta AV (1973) Immune and toxic mechanisms in drug-induced agranulocytosis. Semin Hematol 10: 279–310
Ratzan RJ, Moore MAS, Yunis AA (1974) Effect of Chloramphenicol and Thiamphenicol on the in vitro colony-forming cell. Blood 43: 363–369
Samson JP, Hulstaert CE, Molenaar I, Nieweg HO (1972) Fine structure of the bone marrow sinusoidal wall in idiopathic and drug-induced panmyelopathy. Acta Haematol 48: 218–226
Schultz DR, Walling JS, Yunis AA (1979) Evidence for an immune mechanism in chloramphenicol-induced aplastic anemia. Clin Res 27: 464A
Seed TM, Cullen SM, Kaspar LV, Tolle DV, Fritz TE (1980) Hemopathologic consequences of protracted gamma irradiation: alterations in granulocyte reserves and granulocyte mobilization. Blood 56: 42–51
Silver BJ, Zuckerman KS (1980) Aplastic anemia. Recent advances in pathogenesis and treatment. Med Clin N Am 64: 607–629
Singer JW, Brown JE (1978) In vitro marrow culture techniques in aplastic anaemia and related disorders. Clin Haematol 7: 487–499
Snyder R, Lee EW, Kocsis JJ, Witmer CM (1977) Bone marrow depressant and leukemogenic actions of benzene. Life Sciences 21: 1709–1722
Speck B, Gluckman E, Haak HL, Van Rood JJ (1978) Treatment of aplastic anaemia by antilymphocyte globulin with or without marrow infusion. Clin Haematol 7: 611–621
Sutherland R, Vincent PC, Raik E, Burgess K (1977) Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro. Br Med J 1: 605–607
Trainor KJ, Seshadri RS, Morley AA (1979) Residual marrow injury following cytotoxic drugs. Leuk Res 3: 205–210
Tso SC, Chan TK, Todd D (1977) Aplastic anaemia: A study of prognosis and the effect of androgen therapy. Q J Med 46: 513–529
Vincent PC, de Gruchy GC (1967) Complications and treatment of acquired aplastic anaemia. Br J Haematol 13: 977–999
Vincent PC (1982) Haemopoietic inhibitors in aplastic anaemia — a review. Pathology 14: 25–29
Webley M, Coomes EN (1978) Is penicillamine therapy in rheumatoid arthritis influenced by previous treatment with gold? Br J Med 2: 91
Williams DM, Lynch RE, Cartwright GE (1973) Drug-induced aplastic anemia. Semin Hematol 10: 195–223
Young GAR, Vincent PC (1980) Drug-induced agranulocytosis. Clin Haematol 9: 483–504
Young GAR, Forrest P, Deveridge SF, Gates RB, Vincent PC (1982) Mebhydrolin induced agranulocytosis. Aust NZ J Med 12: 173–176
Yunis AA (1973) Chloramphenicol-induced bone marrow suppression. Semin Hematol 10: 225–234
Yunis AA (1974) Chloramphenicol toxicity. In: Girdwood RH (ed) Blood disorders due to drugs and other agents. Excerpta Med, Amsterdam, pp 107–126
Yunis AA, Adamson JW (1977) Differential in vitro sensitivity of marrow erythroid and granulocytic colony forming cells to chloramphenicol. Am J Hematol 2: 335–363
Yunis AA, Miller AM, Salem Z, Arimura GK (1980) Chloramphenicol toxicity: Pathogenetic mechanisms and the role of the p-NO2 in aplastic anemia. Clin Toxicol 17: 359–373
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vincent, P.C. In vitro evidence of drug action in aplastic anemia. Blut 49, 3–12 (1984). https://doi.org/10.1007/BF00320378
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320378